KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Inovio Pharmaceuticals (INO) over the last 17 years, with Q3 2025 value amounting to $3.4 million.

  • Inovio Pharmaceuticals' Prepaid Assets fell 2639.27% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year decrease of 2639.27%. This contributed to the annual value of $2.5 million for FY2024, which is 5350.17% down from last year.
  • Latest data reveals that Inovio Pharmaceuticals reported Prepaid Assets of $3.4 million as of Q3 2025, which was down 2639.27% from $4.3 million recorded in Q2 2025.
  • Inovio Pharmaceuticals' 5-year Prepaid Assets high stood at $85.3 million for Q3 2021, and its period low was $2.2 million during Q1 2025.
  • In the last 5 years, Inovio Pharmaceuticals' Prepaid Assets had a median value of $5.4 million in 2024 and averaged $26.8 million.
  • In the last 5 years, Inovio Pharmaceuticals' Prepaid Assets soared by 230287.75% in 2021 and then plummeted by 9425.68% in 2023.
  • Over the past 5 years, Inovio Pharmaceuticals' Prepaid Assets (Quarter) stood at $38.8 million in 2021, then grew by 29.08% to $50.1 million in 2022, then plummeted by 89.2% to $5.4 million in 2023, then tumbled by 53.5% to $2.5 million in 2024, then surged by 35.0% to $3.4 million in 2025.
  • Its last three reported values are $3.4 million in Q3 2025, $4.3 million for Q2 2025, and $2.2 million during Q1 2025.